Scientists have found that combining silybin with carvedilol works far better against liver fibrosis than either drug alone.
A newly identified and rare genetic variant slows the growth of mutated blood stem cells and reduces the risk of leukemia.
A study led by Maria Carmo-Fonseca at GIMM has helped clarify one of the main limitations of lab-grown heart cells, which are ...
Chase Markel, a University of Wyoming Ph.D. student from Wheatland, is harnessing artificial intelligence (AI) to transform ...
Pancreatic ductal adenocarcinoma (PDAC) is the most lethal form of pancreas cancer. It's also the most common form of the ...
News Medical on MSN
A repurposed drug duo shows powerful synergy against liver fibrosis
A research team reports a promising new strategy: combining two already-approved drugs—silybin, a natural liver-protective ...
NASA is ramping up work on one large space telescope while also laying the groundwork for future observatories.
Backers claim the tests can predict a child’s risk of autism using a strand of hair or a mother’s blood, but critics say they are not ready for the market.
The Food and Drug Administration has approved Yartemlea ® (narsoplimab-wuug) for the treatment of adult and pediatric patients aged 2 years and older with hematopoietic stem cell transplant ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback